Search Results - "Pascoe, Steven"

Clinical Course and Management of Hypertrophic Cardiomyopathy by Pascoe, Steven J

Get full text

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease by Lipson, David A, Barnacle, Helen, Birk, Ruby, Brealey, Noushin, Locantore, Nicholas, Lomas, David A, Ludwig-Sengpiel, Andrea, Mohindra, Rajat, Tabberer, Maggie, Zhu, Chang-Qing, Pascoe, Steven J

“…Randomized data comparing triple therapy with dual inhaled corticosteroid (ICS)/long-acting β -agonist (LABA) therapy in patients with chronic obstructive…”
Get full text

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD by Lipson, David A, Barnhart, Frank, Brealey, Noushin, Brooks, Jean, Criner, Gerard J, Day, Nicola C, Dransfield, Mark T, Halpin, David M.G, Han, MeiLan K, Jones, C. Elaine, Kilbride, Sally, Lange, Peter, Lomas, David A, Martinez, Fernando J, Singh, Dave, Tabberer, Maggie, Wise, Robert A, Pascoe, Steven J

“…The frequency of COPD exacerbations during treatment with a triple inhaler — delivering a long-acting beta-agonist (LABA), a long-acting muscarinic antagonist…”
Get full text

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials by Pascoe, Steven, Dr, Locantore, Nicholas, PhD, Dransfield, Mark T, Prof, Barnes, Neil C, Prof, Pavord, Ian D, Prof

“…Summary Background The short-term benefits of inhaled corticosteroids for patients with chronic obstructive pulmonary disease (COPD) are greater in patients…”
Get full text

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease by Lipson, David A, Crim, Courtney, Criner, Gerard J, Day, Nicola C, Dransfield, Mark T, Halpin, David M G, Han, MeiLan K, Jones, C Elaine, Kilbride, Sally, Lange, Peter, Lomas, David A, Lettis, Sally, Manchester, Pamela, Martin, Neil, Midwinter, Dawn, Morris, Andrea, Pascoe, Steven J, Singh, Dave, Wise, Robert A, Martinez, Fernando J

“…The IMPACT (Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment) trial demonstrated a significant reduction in all-cause mortality (ACM)…”
Get full text

Blood eosinophil levels as a biomarker in COPD by Brusselle, Guy, Pavord, Ian D., Landis, Sarah, Pascoe, Steven, Lettis, Sally, Morjaria, Nikhil, Barnes, Neil, Hilton, Emma

“…Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder and patients respond differently to treatment. Blood eosinophils are a potential…”
Get full text

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone by Stempel, David A, Raphiou, Ibrahim H, Kral, Kenneth M, Yeakey, Anne M, Emmett, Amanda H, Prazma, Charlene M, Buaron, Kathleen S, Pascoe, Steven J

“…Among more than 11,000 patients with moderate-to-severe asthma, fluticasone–salmeterol was noninferior to fluticasone alone with respect to severe asthma…”
Get full text

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol by Pascoe, Steven J, Lipson, David A, Locantore, Nicholas, Barnacle, Helen, Brealey, Noushin, Mohindra, Rajat, Dransfield, Mark T, Pavord, Ian, Barnes, Neil

“…Patients with symptomatic advanced chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations are particularly at risk of poor…”
Get full text

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma by Stempel, David A, Szefler, Stanley J, Pedersen, Søren, Zeiger, Robert S, Yeakey, Anne M, Lee, Laurie A, Liu, Andrew H, Mitchell, Herman, Kral, Kenneth M, Raphiou, Ibrahim H, Prillaman, Barbara A, Buaron, Kathleen S, Yun Kirby, Suyong, Pascoe, Steven J

“…This large trial involving children with asthma examined whether the addition of a long-acting beta-agonist to current therapy with inhaled glucocorticoids…”
Get full text

Understanding asthma-chronic obstructive pulmonary disease overlap syndrome by Wurst, Keele E, Kelly-Reif, Kaitlin, Bushnell, Greta A, Pascoe, Steven, Barnes, Neil

“…Abstract Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) is a loosely-defined clinical entity referring to patients who exhibit…”
Get full text

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease by Pascoe, Steven J, Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil

“…Patients with chronic obstructive pulmonary disease (COPD) have excess risk of developing pneumonia; however, no definitive biomarkers of risk have been…”
Get full text

Clinical Course and Management of Hypertrophic Cardiomyopathy by Bachmayer, Karl, Pascoe, Steven J, Maron, Barry J

“…To the Editor: In his review article, Maron (Aug. 16 issue) 1 does not mention the potential of physical examination in patients with hypertrophic…”
Get full text

The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease by Cooper, Christopher B, Brusselle, Guy, Pascoe, Steven J, Pavord, Ian D

Get full text

No dose effect observed with chronic fluticasone propionate on growth velocity in children by Lee, Laurie A., Pedersen, Søren, Pascoe, Steven J., Szefler, Stanley J., Lenney, Warren, Kalaycı, Ömer

Get full text

Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap by Nelsen, Linda M, Lee, Laurie A, Wu, Wei, Lin, Xiwu, Murray, Lindsey, Pascoe, Steven J, Leidy, Nancy K

“…The Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonary Disease (E-RS:COPD) is a patient-reported diary that assesses respiratory symptoms in…”
Get full text

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids by Kerwin, Edward, Pascoe, Steven, Bailes, Zelie, Nathan, Robert, Bernstein, David, Dahl, Ronald, von Maltzahn, Robyn, Robbins, Kevin, Fowler, Andrew, Lee, Laurie

“…Patients with asthma uncontrolled on inhaled corticosteroids may benefit from umeclidinium (UMEC), a long-acting muscarinic antagonist. This Phase IIb,…”
Get full text

Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease by Lipson, David A, Barnacle, Helen, Birk, Ruby, Brealey, Noushin, Locantore, Nicholas, Lomas, David A, Ludwig-Sengpiel, Andrea, Mohindra, Rajat, Tabberer, Maggie, Zhu, Chang-Qing, Pascoe, Steven J

Get full text

Reply to Suissa and Ariel: The FULFIL Trial by Lipson, David A, Barnacle, Helen, Birk, Ruby, Brealey, Noushin, Locantore, Nicholas, Lomas, David A, Ludwig-Sengpiel, Andrea, Mohindra, Rajat, Tabberer, Maggie, Zhu, Chang-Qing, Pascoe, Steven J

Get full text

Reply: "FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease" and "Triple Therapy in Chronic Obstructive Pulmonary Disease" by Lipson, David A, Barnacle, Helen, Birk, Ruby, Brealey, Noushin, Locantore, Nicholas, Lomas, David A, Ludwig-Sengpiel, Andrea, Mohindra, Rajat, Tabberer, Maggie, Zhu, Chang-Qing, Pascoe, Steven J

Get full text

Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease? by Patel, Mehul S, McKie, Elizabeth, Steiner, Michael C, Pascoe, Steven J, Polkey, Michael I

“…Hypoxia is common in many chronic lung diseases. Beyond pulmonary considerations, delivery of oxygen (O2) to the tissues and subsequent O2 utilisation is also…”
Get full text